Skip over main navigation
  • Log in
  • Basket: (0 items)
Solving Kids' Cancer
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
Shop Contact us Donate
Menu
  • About Neuroblastoma
    • About Neuroblastoma Home
    • What is neuroblastoma?
    • Symptoms
    • Diagnosis
    • Risk Groups and Staging
    • Clinical Trials
    • Treatment for Neuroblastoma
  • Find Support
    • Family support
    • The Big Love Fund
    • Care & Connect
    • Access treatment
    • Neuroblastoma Parent Education Conference
      • Neuroblastoma Parent Global Symposium 2021
      • See past conferences
    • Other sources of help
  • Research
    • Our research
    • Scientific Advisory Board
    • Research Funding
      • Funding award process
      • Grant Award Calls
    • Projects
    • Funding partners
    • Research policies
    • Research blog
  • Get Involved
    • Help Us Today
    • Support The Big Love Fund
    • Childhood Cancer Awareness Month
    • Shop
    • Ambassador Programme
    • Corporate partnerships
    • Challenge events
    • Set up a fundraising page
    • Gaming
    • Fundraising resources
  • Children’s stories
    • Stories
    • Children’s campaigns
    • In memory
    • Named funds
  • About us
    • What we do
    • Meet the team
      • Trustees
      • Our team
    • Patrons
    • Parent Involvement Forum
    • Join our Team
    • Annual reports
  • News
    • News
    • Blogs
  • Admin
    • Log in
  • Basket: (0 items)
  • Access Treatment

Access Treatment

High-risk neuroblastoma is treated with intense and aggressive multimodal therapy and clinical research is ongoing worldwide to test better and kinder treatments that improve outcomes for children.

Treating high-risk neuroblastoma successfully is particularly challenging. No diagnosis is the same and patients will respond differently to multimodal therapies. Some families, working with their consultants, will explore further treatment options available within the UK and sometimes families may consider treatment options which are outside of the UK.

Providing information about treatment and clinical trials

Our Family Support Team has personal experience and truly understands. While we are happy to help families to understand treatment options with impartial and evidence-based information, we encourage all families to speak with their child's oncologist first and discuss anything treatment related with them.

Our in-depth knowledge of the global clinical trial landscape means we can help families to understand and interpret the information relevant to them and their child. One of the most effective ways we facilitate this support is through our annual Neuroblastoma Parent Education Conference. Families get the chance to learn about some of the most innovative and up to date neuroblastoma research and treatments from expert neuroblastoma researchers and clinicians.

A photo showing a conference audience and projector screen

Accessing treatment in the UK

There is a distinct 'frontline treatment' pathway in the UK that aims to reduce the size of the primary tumour with chemotherapy, remove as much of the tumour as possible with surgery, achieve remission and then try to ensure the cancer does not return.

If your child requires treatment for relapse (when the cancer comes back) or refractory (disease that isn't responding to treatment) then this could be further chemotherapy, radiotherapy, surgery or antibody therapy. But there are also clinical trial options where new drugs are being tested.

Solving Kids' Cancer is committed to providing children and young people with neuroblastoma more and better treatment options in the UK and we facilitate access to the best available treatments and clinical trials in this country. It's important to remember that these treatments have not been proven to work on children with neuroblastoma and this is why they are clinical trials.

Sometimes though, there are options for treatment that are not available on the NHS and lie abroad at international institutions. 

Accessing treatment abroad

Treatment options outside of the UK can often cost hundreds of thousands of pounds and may require significant fundraising.

Solving Kids' Cancer fully supports a parent's choice to access treatment, or not, which is their decision entirely, and we don't advocate for any specific access to treatment. If families choose a treatment option that is not available on the NHS, Solving Kids' Cancer can set up and oversee a fundraising campaign.

It helps families to ensure good governance, setting realistic fundraising targets and handling the administration - including claiming Gift Aid.

Raising funds can be very overwhelming and a huge burden on families already going through the toughest of times with their child's cancer diagnosis and treatment. We are here to support families if they are faced with the prospect of raising significant funds. 

Reuben holds up a small American flag as he poses for a photo in New York

Our experience, knowledge and network allow us to support families to access their chosen treatment. This includes:

  • Connecting families with hospitals and helping them to register their child
  • Negotiating the best possible treatment price
  • Arranging flights and accommodation
  • Providing grants to families to cover their day to day costs
  • Supporting families to access the scans their child needs throughout treatment

We've been supporting families who decide to access treatment abroad since 2006. Here's Reuben who accessed the Bivalent Vaccine clinical trial in New York during 2018 and 2019.

 

Published: 7th May, 2019

Updated: 19th August, 2019

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • 100 Miles for Jessica

    100 Miles for Jessica

    To help raise money for critical treatment for Jessica Butler

  • Lucy’s Skydive for Jude

    Lucy’s Skydive for Jude

    I am taking on this challenge to fundraise to help get my son, Jude, to target to access the bivalent vaccine in New York

  • Raffle for Jude

    Raffle for Jude

    Jude is 4. He lives in Sheffield with his family. He is battling cancer & needs pioneering treatment in America. We can help get him there…

  • Rock N Roll for Kayla

    Rock N Roll for Kayla

    Kayla from Norwich is facing a huge challenge, so rock n rollers unite.

Most read

  • Beau's Campaign

    Beau's Campaign

    Beau was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in December 2020. Her family are appealing for your help to raise £317,000 by May 2022.

  • Flora's Campaign

    Flora's Campaign

    In January 2021 Flora was diagnosed with Autism Spectrum Disorder, and just three months later her parents were given the devastating news she had high-risk neuroblastoma. Her family are appealing for your help to raise £252,000 by August 2022 for Flora to enrol on the Bivalent Vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.

  • Jude's Campaign

    Jude's Campaign

    Jude is a Dinosaur and animal-loving three-year-old. In July 2021 Jude was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.

  • Joseph Yeandle

    Joseph Yeandle

    We are devastated to share the news that beautiful Joseph has sadly passed away.

  • Maysaa's Campaign

    Maysaa's Campaign

    Four-year-old Maysaa was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in March 2021. Her family are asking for your support to raise £106,000 by August 2022 for Maysaa to enrol on the DFMO study in Charlotte that aims to stop her neuroblastoma from coming back.

  • Chloe’s Journey

    Chloe’s Journey

    Beautiful Chloe passed away on the 4th of February 2022.

  • Eden's Campaign

    Eden's Campaign

    Six-year-old Eden was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in April 2021.

  • Kayla's Campaign

    Kayla's Campaign

    Three-year-old Kayla was diagnosed with high-risk neuroblastoma in May 2021. Kayla’s parents are asking for your help to raise £221,000 by November 2022 for Kayla to enrol on the bivalent vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.

  • Peter's Campaign

    Peter's Campaign

    11-year-old Peter was diagnosed with neuroblastoma in early 2019. Devastatingly he relapsed in August 2020 after being clear of disease for 6 months. Thanks to your incredible fundraising and support, Peter was able to enrol on the DFMO study in Charlotte at the end of January 2022.

  • Dulcie's Campaign

    Dulcie's Campaign

    In December 2021, five-year-old Dulcie was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Contact us

Solving Kids' Cancer UK
Coram Campus
41 Brunswick Square
London
WC1N 1AZ

Phone: 020 7284 0800

Follow us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn

  • Jobs
  • Media enquiries
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Safeguarding Statement
  • Complaints and Compliments
  • Privacy Policy

Solving Kids’ Cancer UK is a registered charity in England and Wales (1135601), and in Scotland (SCO45094). It is a company limited by guarantee in England and Wales (7208648). The charity and company is currently operating as Solving Kids’ Cancer.